Detalhe da pesquisa
1.
Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer.
Cochrane Database Syst Rev
; 2: CD008593, 2016 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869023
2.
Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site.
Psychooncology
; 22(9): 2009-15, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359412
3.
USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development.
Stem Cell Reports
; 18(2): 570-584, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669491
4.
Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells.
Cancer Res
; 82(9): 1762-1773, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247890
5.
Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource.
Genome Biol
; 23(1): 35, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078504
6.
The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens.
Genome Biol
; 20(1): 1, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30606230
7.
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.
J Clin Oncol
; 35(16): 1778-1785, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28388291
8.
Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma.
Diseases
; 3(4): 294-305, 2015 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28943626
9.
A case-control study on the rs3130932 single nucleotide polymorphism in the OCT4B translation initiation codon in association with cancer state.
Eur J Cancer Prev
; 20(3): 248-51, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21301344
10.
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.
Anticancer Res
; 31(9): 3007-18, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21868552